AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.160
+0.380 (13.67%)
At close: Feb 6, 2026, 4:00 PM EST
3.220
+0.060 (1.91%)
After-hours: Feb 6, 2026, 7:52 PM EST
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $945.9 million as of February 6, 2026. Its market cap has decreased by -9.02% in one year.
Market Cap
945.90M
Enterprise Value
592.44M
1-Year Change
-9.02%
Ranking
Category
Stock Price
$3.16
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $945.90M, a decrease of -93.96%. That is a compound annual growth rate of -41.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 945.90M | -7.60% |
| Dec 31, 2025 | 1.02B | 18.29% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ventyx Biosciences | 1.00B |
| Vir Biotechnology | 1.00B |
| UroGen Pharma | 999.37M |
| Aktis Oncology | 996.87M |
| ARS Pharmaceuticals | 991.45M |
| Phathom Pharmaceuticals | 984.95M |
| Geron | 976.68M |
| Palvella Therapeutics | 972.96M |